A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis

NCT03725202 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

429

Enrollment

INDUSTRY

Sponsor class

Conditions

Giant Cell Arteritis (GCA)

Interventions

DRUG: Upadacitinib
DRUG: Corticosteroid (CS)
OTHER: Placebo

Sponsor

AbbVie